OPENCORONA: Accelerating pandemic preparedness with DNA vaccine manufacturing
NorthX Biologics delivers plasmid DNA for COVID-19 vaccine development In the early days of the COVID-19 pandemic, NorthX Biologics took a bold step by joining a pan-European, EU-funded scientific consortium, ...
Lessons learned from a pandemic vaccine consortium
Published in Vaccine Insights (2023) (OPENCORONA: lessons learned from a pandemic vaccine consortium), this interview highlights the EU-funded OPENCORONA project, a pan-European consortium formed in early 2020 to develop a ...
NorthX Plasmid Solutions
NorthX Biologics is providing expert plasmid DNA solutions for all phases ranging from early pre-clinical through to commercial manufacture. We offer a range of plasmid qualities with the right level ...
Plasmid DNA – The right quality for each application
With the tremendous advances in cell and gene therapies, and the unprecedented success of vaccines based on nucleic acid seen during the Covid pandemic, the need for high quality plasmid ...
QC in ATMP production: Sailing a stormy sea, what’s the key?
Medicines based on genes, cells, or tissue engineering, i.e. Advanced Therapy Medicinal Products (ATMPs) are a rising star shining brighter and brighter in the horizon for any CDMO operating in ...
NorthX Biologics – A new kind of biologics company
NorthX Biologics is an established provider of process development and manufacturing services with expertise in the biologics used in vaccines, gene therapy and other advanced applications. Headquartered in Matfors in ...
Finding your match in the biotech world: The CDMO dating game
In the dynamic and complex world of pharmaceuticals and drug development, the quest to find the right Contract Development and Manufacturing Organization (CDMO) often feels akin to searching for a ...
Navigating the production of non-GMP proteins in a GMP-driven environment
As the pharmaceutical and biotechnological industries are obliged to align their operations with Good Manufacturing Practice (GMP) guidelines, a unique set of challenges emerges for facilities tasked with producing non-GMP ...
Check out the new conference insight on what’s cooking in the ATMP space
Current trends in ATMPs This article is written by Helena Strigård and Jonathan Royce. Having returned from a series of conferences staged in the spring of 2023, when barely any ...